Antibody evolution immunogens
Patent
·
OSTI ID:1771680
The present invention relates, in general, to HIV-1 and, in particular, to broadly neutralizing HIV-1 antibodies, and to HIV-1 immunogens and to methods of using such immunogens to induce the production of broadly neutralizing HIV-1 antibodies in a subject (e.g., a human).
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-06NA25396
- Assignee:
- Duke University (Durham, NC); Triad National Security, LLC (Los Alamos, NM); The Trustees of the University of Pennsylvania (Philadelphia, PA); TRUSTEES OF BOSTON UNIVERSITY (Boston, MA); The United States of America, as represented by the Secretary, Department of Health and Human Services (Rockville, MD); The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA)
- Patent Number(s):
- 10,849,970
- Application Number:
- 15/864,822
- OSTI ID:
- 1771680
- Resource Relation:
- Patent File Date: 01/08/2018
- Country of Publication:
- United States
- Language:
- English
Similar Records
Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins
Polyvalent immunogen
Patent
·
Tue Dec 26 00:00:00 EST 2006
·
OSTI ID:1771680
Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins
Patent
·
Tue Dec 06 00:00:00 EST 2011
·
OSTI ID:1771680
+6 more
Polyvalent immunogen
Patent
·
Tue Feb 06 00:00:00 EST 2007
·
OSTI ID:1771680
+1 more